i10 Productivity
Rankings
Pfizer Inc. Scientists i10 Productivity Rankings 2024
Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Click for "last 6 years' i10 index". Also see: Universities Rankings 2024 (Sort by : Total i10 Index) and Universities Rankings 2024 (Sort by : Last 6 Years i10 Index)
| Total i10 Index | AD Scientific Index - World Scientists i10 Productivity Rankings - 2024 | i10 Index Metrics | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| University Rank | Country Rank | Region Rank | World Rank | Name | Country | University / Institution |
Subject Research Areas |
Total | Last 6 Year | Last 6 year/total |
| 1 | 4,076 | 4,533 | 11,861 |
United States |
Pfizer Inc.
|
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
drug metabolism | clinical pharmacology | phamacometrics | |
309 | 146 | 0.472 | |
| 2 | 4,864 | 5,427 | 14,224 |
United States |
Pfizer Inc.
|
Others
rare disease | gene therapy | |
287 | 167 | 0.582 | |
| 3 | 5,154 | 5,746 | 15,056 |
United States |
Pfizer Inc.
|
Medical and Health Sciences / Biostatistics
health measurement scales | meta-analysis | |
280 | 188 | 0.671 | |
| 4 | 14,498 | 16,374 | 43,969 |
United States |
Pfizer Inc.
|
Engineering & Technology / Computer Science
Data management. Data integration and visualization. Platform development. Software Solution Development. | |
170 | 75 | 0.441 | |
| 5 | 15,509 | 17,510 | 47,168 |
United States |
Pfizer Inc.
|
Others
in vitro toxicology | predictive tox | developmental and reproductive toxicology | |
164 | 75 | 0.457 | |
| 6 | 15,801 | 17,846 | 48,080 |
United States |
Pfizer Inc.
|
Others
|
162 | 111 | 0.685 | |
| 7 | 15,910 | 17,973 | 48,457 |
United States |
Pfizer Inc.
|
Engineering & Technology / Computer Science
Data Science | Machine Learning | Drug Development | Clinical Trials | Medical Informatics | |
161 | 135 | 0.839 | |
| 8 | 21,470 | 24,379 | 67,081 |
United States |
Pfizer Inc.
|
Medical and Health Sciences / Endocrinology and Metabolism
Toxicology | Molecular Toxicology | Endocrinology | microRNA | |
135 | 67 | 0.496 | |
| 9 | 22,400 | 25,437 | 70,257 |
United States |
Pfizer Inc.
|
Others
powder compaction flow segregation computational modeling | |
131 | 102 | 0.779 | |
| 10 | 28,433 | 32,332 | 91,161 |
United States |
Pfizer Inc.
|
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Pfizer Global R&D | |
112 | 96 | 0.857 | |
|
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
|
||||||||
| 11 | 28,804 | 32,779 | 92,526 |
United States |
Pfizer Inc.
|
Natural Sciences / Biological Science
vaccines | virology | structural biology | |
111 | 92 | 0.829 | |
| 12 | 34,415 | 39,287 | 112,873 |
United States |
Pfizer Inc.
|
Medical and Health Sciences / Health Sciences
patient preference | |
98 | 72 | 0.735 | |
| 13 | 34,560 | 39,458 | 113,435 |
United States |
Pfizer Inc.
|
Others
Drug Development | Positron Emission Tomography | Biomarkers | Imaging | Digital Medicine | |
98 | 52 | 0.531 | |
| 14 | 35,976 | 41,061 | 118,419 |
United States |
Pfizer Inc.
|
Natural Sciences / Biological Science
Protein engineering | Antibodies | Structural Biology | Immunology | Biochemistry | |
95 | 67 | 0.705 | |
| 15 | 37,738 | 43,050 | 124,596 |
United States |
Pfizer Inc.
|
Others
|
92 | 51 | 0.554 | |
| 16 | 43,241 | 49,362 | 145,042 |
United States |
Pfizer Inc.
|
Others
|
83 | 35 | 0.422 | |
| 17 | 44,142 | 50,377 | 148,379 |
United States |
Pfizer Inc.
|
Others
vaccines | infectious diseases | clinical trials | epidemiology | |
81 | 69 | 0.852 | |
| 18 | 45,040 | 51,413 | 151,715 |
United States |
Pfizer Inc.
|
Engineering & Technology / Computer Science
Clinical Trials | Data MiningFirst interest | Second interest | |
80 | 55 | 0.688 | |
| 19 | 45,725 | 52,217 | 154,447 |
United States |
Pfizer Inc.
|
Medical and Health Sciences / Dermatology and Venereology
Dermatology | Immunology | Oncology | |
79 | 51 | 0.646 | |
| 20 | 45,966 | 52,493 | 155,372 |
United States |
Pfizer Inc.
|
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Medicinal chemistry | |
79 | 24 | 0.304 | |
| 21 | 46,699 | 53,336 | 158,089 |
United States |
Pfizer Inc.
|
Others
pneumococcal vaccines | |
78 | 25 | 0.321 | |
| 22 | 48,133 | 54,973 | 163,421 |
United States |
Pfizer Inc.
|
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Medicinal Chemistry | |
76 | 38 | 0.500 | |
| 23 | 49,547 | 56,593 | 169,007 |
United States |
Pfizer Inc.
|
Medical and Health Sciences / General Surgery
Surgery | Combination Products | Medical devices | Image-Guided Interventions | Robotics | |
74 | 44 | 0.595 | |
| 24 | 50,318 | 57,478 | 171,990 |
United States |
Pfizer Inc.
|
Natural Sciences / Molecular Biology & Genetics
Genetic Epidemiology | COPD | Parkinson disease | |
73 | 46 | 0.630 | |
| 25 | 51,265 | 58,551 | 175,657 |
United States |
Pfizer Inc.
|
Engineering & Technology / Metallurgical & Materials Engineering
NMR | Materials science | BioPharma | |
72 | 37 | 0.514 | |